Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Medigene AG
MDGEFCurrent price
2.59 USD
0 USD (0.00%)
Last closed
1.49 EUR
Company
www.medigene.com
ISIN
DE000A1X3W00
Sector
Healthcare
Industry
Biotechnology
Exchange
XETRA
Capitalization
22 097 080 EUR
Yield for 12 month
-55.53 %
1Y
3Y
5Y
10Y
15Y
MDGEF
Medigene AG, a biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer. The company's end-to-end platform enables the development of T cell receptor engineered T cell (TCR-T) therapies for multiple tumor indications. Its pipeline includes MDG1015, a TCR-T therapy product to treat multiple solid tumor indications; MDG10xx to treat multiple solid tumor; and MDG1011, a TCR-T immunotherapy candidate, which is in clinical development to treat blood cancer. It also focuses on dendritic cell vaccines. Medigene AG has a strategic partnership with BioNTech to develop TCRbased immunotherapies against cancer; and 2seventy bio, Inc. for the development of TCR immunotherapies, as well as a collaboration agreement with National Cancer Institute to evaluate the potential of T cell receptors to be used in new cell constructs for the treatment of solid tumors. It has operations in Germany, the United States, and Asia. The company has research collaboration with WuXi Biologics to design and co-research TCR-guided T Cell engagers (TCR-TCEs) for the treatment of difficult-to-treat tumors. Medigene AG was founded in 1994 and is headquartered in Munich, Germany. Address: Lochhamer Strasse 11, Munich, Germany, 82152
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5.65 EURP/E ratio
–Dividend Yield
–Current Year
+6 055 679 EUR
Last Year
+31 359 264 EUR
Current Quarter
+1 462 235 EUR
Last Quarter
+2 246 041 EUR
Current Year
+2 991 710 EUR
Last Year
+29 369 140 EUR
Current Quarter
+1 128 038 EUR
Last Quarter
+1 858 152 EUR
Key Figures MDGEF
1 year
3 years
5 years
10 years
EBITDA
-14 834 105 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-27.15 %
PEG Ratio
–
Return On Equity TTM
-63.93 %
Wall Street Target Price
5.65 EUR
Revenue TTM
7 472 752 EUR
Book Value
1.34 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-6 %
Dividend Yield
–
Gross Profit TTM
29 369 140 EUR
Earnings per share
-1.21 EUR
Diluted Eps TTM
-1.21 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-213.98 %
Dividend Analytics MDGEF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MDGEF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:2
Payout Ratio
–
Last Split Date
29.08.2024
Dividend Date
–
Stock Valuation MDGEF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.4154
Price Sales TTM
2.957
Enterprise Value EBITDA
1.8128
Price Book MRQ
1.1199
Financials MDGEF
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MDGEF
For 52 weeks
1.43 EUR
5.53 EUR
50 Day MA
1.91 EUR
Shares Short Prior Month
–
200 Day MA
2.6 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart